Polatuzumab, Bendamustine & Rituximab (Pola-Br) Efficacy In Relapsed/Refractory Diffuse Large B Cell Lymphoma (Rrdlbcl) Trial-Ineligible Patients: An Australian Lymphoma Registry (Lardr) Study
Bendamustine;Polatuzumab;Rituximab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Polatuzumab, Bendamustine & Rituximab (Pola-Br) Efficacy In Relapsed/Refractory Diffuse Large B Cell Lymphoma (Rrdlbcl) Trial-Ineligible Patients: An Australian Lymphoma Registry (Lardr) Study ### Output: Bendamustine;Polatuzumab;Rituximab